[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334608-105":59,"doc-detail-334608-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","pleomorphicsolid-lobular-carcinoma-of-male-breast-with-palb2-germline-mutation-case-report-and-literature-review","Pleomorphic/solid lobular carcinoma of male breast with PALB2 germline mutation - case report and literature review","","Pleomorphic/solid lobular carcinoma of male breast is presented as a rare, aggressive infiltrating lobular carcinoma variant. Male breast cancer represents about 1% of all breast cancers, and infiltrating lobular carcinomas account for only 1–2% of male cases. The report describes an invasive pleomorphic/solid lobular carcinoma carrying a pathogenic PALB2 germline variant, alongside a family history of breast cancer without other clearly defined risk factors. Current literature on this association is reviewed, emphasizing that PALB2-mutated male ILC has not previously been reported.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pleomorphicsolid-lobular-carcinoma-of-male-breast-with-palb2-germline-mutation-case-report-and-literature-review/334608/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pleomorphicsolid-lobular-carcinoma-of-male-breast-with-palb2-germline-mutation-case-report-and-literature-review/334608.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-22","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is male lobular carcinoma with PALB2 germline mutation considered rare?","Question",{"text":113,"@type":114},"The article notes that infiltrating lobular carcinoma is uncommon in men (about 1–2% of male breast cancer cases) and pleomorphic invasive lobular carcinoma has only limited male cases reported. It also states that PALB2 mutations in male ILC have not been previously reported.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What clinical and histopathological features were observed in the case?",{"text":118,"@type":114},"A 46-year-old man presented with a 4 cm irregular left breast mass. Core biopsies showed pleomorphic nuclei with eosinophilic cytoplasm, prominent nucleoli, high mitotic count, apoptotic bodies, and areas of necrosis.",{"name":120,"@type":111,"acceptedAnswer":121},"What immunohistochemistry and HER2 findings were reported?",{"text":122,"@type":114},"Tumor cells lacked E-cadherin expression and were estrogen receptor and progesterone receptor positive with a high Ki-67 proliferation index. HER2 was scored 2+ by immunohistochemistry, but gene amplification was not detected by SISH analysis.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},334608,1790517040,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","PATHOLOGICA 2024;116:62-68; DOI: 10.32074/1591-951X-936  \nReceived: October 13, 2023  \nAccepted: December 15, 2023  \nCorrespondence  \nEvelina Rogges  \nE-mail: [evelina.rogges@uniroma1.it](evelina.rogges@uniroma1.it)  \nHow to cite this article: Rogges E, Corati T, Amato M, et al. Pleomorphic/solid lobular carcinoma of male breast with PALB2 germline mutation: case report and literature review. Pathologica 2024;116:62-68 . [https://](https://)[ ](https://)[doi.org/10.32074/1591-951X-936](doi.org/10.32074/1591-951X-936)  \n© Copyright by Società Italiana di Anatomia Patologica e Citopatologia Diagnostica, Divisione Italiana della International Academy of Pathology  \n OPEN ACCESS  \nThis is an open access journal distributed in accordance with the CC-BY-NC-ND (Creative Commons AttributionNonCommercial-NoDerivatives 4.0 International) license: the work can be used by mentioning the author and the license, but only for non-commercial purposes and only in the original version. For further information: [https://creativecommons](https://creativecommons). org/licenses/by-nc-nd/4.0/deed.en  \nCase Report  \nPleomorphic/solid lobular carcinoma of male breast with PALB2 germline mutation: case report and literature review  \nEvelina Rogges1,2 , Tiberio Corati1,2 , Michelina Amato1 , Domenico Campagna1 , Juliette Farro3 , Simona De Toffol4 , Lucio Fortunato5 , Leopoldo Costarelli1  \n1 Department of Pathology, San Giovanni-Addolorata Hospital, Rome, Italy; 2 Department of Clinical and Molecular Medicine, Sant’Andrea Hospital, Sapienza University, Rome, Italy; 3 Department of Genetics, San Giovanni-Addolorata Hospital, Rome, Italy; 4 Laboratory of Medical Genetics, TOMA Advanced Biomedical Assays S.p.A., Busto Arsizio VA, Italy; 5 Breast Center, Department of Surgery, San Giovanni-Addolorata Hospital, Rome, Italy  \nSummary  \nMale breast cancer (MBC) accounts for approximately 1% of all breast cancers and among these infiltrating lobular carcinomas (ILC) represents only 1-2% of all MBC cases. Pleomorphic invasive lobular carcinoma (PILC) is an aggressive variant of ILC with only eight cases reported until now in males. Up to 10% of MBC cases have a germline pathogenic variant in a predisposing gene such as BRCA1 and BRCA2 genes. Mutations in PALB2 (partner and localizer of BRCA2) have been reported in men with breast cancer, with a frequency that ranges from 0.8 to 6.4%, but it has never been reported in male ILC. Here, we report a rare and interesting case of an invasive pleomorphic/solid lobular carcinoma, which carries a pathogenic variant in PALB2 gene, and a family history of breast cancer without other well defined risk factors for developing this type of neoplasia. In addition, wereview the current literature.  \nKey words: male breast cancer (MBC), lobular carcinoma (LC), PALB2,germline mutations  \nIntroduction  \nMale breast cancer (MBC) accounts for approximately 1% of all breast cancers, and its incidence has been increasing over the years. The mean age at diagnosis is 5 years later for men than for women, and the risk is about 100 times less common among white men than among white women, and 70 times less common among black men than black women 1-3. The most common histological subtype is invasive carcinoma of no special type (IBC, NST) . Risk factors for MBC are well known and include increasing age 3 , black race 2,4 and family history 5 as demographic characteristics, genetic alteration, like mutation in the most well characterized BRCA1 and BRCA2 1 , and in other genes like CHEK2 , PALB2 , PTEN and TP53 6-8 and lastly liver disease, increased serum estradiol, Klinefelter’s syndrome, gynecomastia, obesity, and testicular abnormalities accounting for hormonal alterations 9-13. Although infiltrating lobular carcinomas (ILC) account for approximately 12% of invasive cancers in women, this subtype is very rare among men, accounting for only 1 to 2% of total cases of MBC, and this is probably due to the absence of acini and lobules in male ","cbCaidELM4dtct0V","https://ap.wps.com/l/cbCaidELM4dtct0V","pdf",1224880,"English","# Summary\n# Introduction\n# Case presentation","[{\"question\":\"Why is male lobular carcinoma with PALB2 germline mutation considered rare?\",\"answer\":\"The article notes that infiltrating lobular carcinoma is uncommon in men (about 1–2% of male breast cancer cases) and pleomorphic invasive lobular carcinoma has only limited male cases reported. It also states that PALB2 mutations in male ILC have not been previously reported.\"},{\"question\":\"What clinical and histopathological features were observed in the case?\",\"answer\":\"A 46-year-old man presented with a 4 cm irregular left breast mass. Core biopsies showed pleomorphic nuclei with eosinophilic cytoplasm, prominent nucleoli, high mitotic count, apoptotic bodies, and areas of necrosis.\"},{\"question\":\"What immunohistochemistry and HER2 findings were reported?\",\"answer\":\"Tumor cells lacked E-cadherin expression and were estrogen receptor and progesterone receptor positive with a high Ki-67 proliferation index. HER2 was scored 2+ by immunohistochemistry, but gene amplification was not detected by SISH analysis.\"}]","Pleomorphic/solid lobular carcinoma of male breast with PALB2 germline mutation - case report and literature review | PDF",1790007452,18]